Global RNAi for Therapeutic Market Analysis 2011-2017 and Forecast 2018-2023
Snapshot
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of RNAi for Therapeutic by product, region and application, in addition, this report introduces market competition situation among the companies and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Vendors of Product Type etc.):
siRNA
miRNA
shRNA
Vendors Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Cancer
Cardiovascular
HBV
Other
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of RNAi for Therapeutic by product, region and application, in addition, this report introduces market competition situation among the companies and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Vendors of Product Type etc.):
siRNA
miRNA
shRNA
Vendors Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Cancer
Cardiovascular
HBV
Other
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
